Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Relief For UniQure Hemophilia Program Sends Ball To FTC’s Court
Good News For Gene Therapy Continues As FDA Also Removes Hold On Voyager’s Huntington’s Trial
Apr 26 2021
•
By
Alaric DeArment
FDA lifts hold on uniQure's hemophilia B program • Source: Shutterstock
More from Clinical Trials
More from R&D